$LNBY
Landbay Inc

2023 Q3 Form 10-Q Financial Statement

#000149315223027343 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $3.178K
YoY Change
Cost Of Revenue $2.872K
YoY Change
Gross Profit $306.00
YoY Change
Gross Profit Margin 9.63%
Selling, General & Admin $8.100K
YoY Change 14.89%
% of Gross Profit 2647.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.095K $16.80K
YoY Change 14.86% -19.67%
Operating Profit -$7.789K -$16.80K
YoY Change 10.51% 23.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$57.00 $20.00
YoY Change
Pretax Income -$7.850K
YoY Change 11.35%
Income Tax
% Of Pretax Income
Net Earnings -$7.846K -$16.78K
YoY Change 11.32% 23.7%
Net Earnings / Revenue -246.88%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.460K
YoY Change 40.0%
Cash & Equivalents $5.462K $2.875K $8.105K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $4.622K $7.494K $7.494K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.08K $10.37K $15.60K
YoY Change -33.5% -60.83% -55.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.08K $10.37K $15.60K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.08K $10.37K $15.60K
YoY Change -33.5% -60.83% -55.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.500K $5.100K
YoY Change -7.74%
Deferred Revenue
YoY Change
Short-Term Debt $116.2K
YoY Change 41.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $119.0K $111.4K $99.85K
YoY Change 44.43% 28.6% 22.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $119.0K $111.4K $99.85K
Total Long-Term Liabilities $0.00
Total Liabilities $119.0K $111.4K $99.85K
YoY Change 44.43% 28.6% 22.01%
SHAREHOLDERS EQUITY
Retained Earnings -$464.5K -$456.7K -$439.9K
YoY Change 9.86% 9.83% 9.36%
Common Stock $30.00K $30.00K $30.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$108.9K -$101.0K -$84.26K
YoY Change
Total Liabilities & Shareholders Equity $10.08K $10.37K $15.60K
YoY Change -33.5% -60.83% -55.75%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$7.846K -$16.78K
YoY Change 11.32% 23.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $11.94K -$12.08K
YoY Change -150.06% -3705.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.500K $6.848K
YoY Change 648.03%
NET CHANGE
Cash From Operating Activities 11.94K -$12.08K
Cash From Investing Activities
Cash From Financing Activities 9.500K $6.848K
Net Change In Cash 21.44K -$5.230K
YoY Change -194.95% -1661.19%
FREE CASH FLOW
Cash From Operating Activities $11.94K -$12.08K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001672572
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-56182
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Landbay Inc
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1260549
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
36-25 Main Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
CY2023Q2 dei City Area Code
CityAreaCode
917
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
232-5799
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30000000 shares
CY2023Q2 us-gaap Cash
Cash
2875 usd
CY2023Q1 us-gaap Cash
Cash
8105 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7494 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7494 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
10369 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
15599 usd
CY2023Q2 us-gaap Assets
Assets
10369 usd
CY2023Q1 us-gaap Assets
Assets
15599 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
398 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5100 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
106304 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
99456 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
111404 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
99854 usd
CY2023Q2 us-gaap Liabilities
Liabilities
111404 usd
CY2023Q1 us-gaap Liabilities
Liabilities
99854 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456694 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-439914 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10369 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15599 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7348 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
7348 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16800 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20913 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
16800 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
20913 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16800 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13565 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13565 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-46588 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-46588 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13565 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-60153 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-60153 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13565 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9115 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5100 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5528 usd
CY2023Q2 LNBY Increase Decrease In Other Tax Payable
IncreaseDecreaseInOtherTaxPayable
-398 usd
CY2022Q2 LNBY Increase Decrease In Other Tax Payable
IncreaseDecreaseInOtherTaxPayable
-743 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12078 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
335 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6848 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6848 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5230 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
335 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8105 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26140 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2875 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26475 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
743 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zv1XRkQPfKii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zZQCI4JTJpPl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets and liabilities, and the disclosure of contingent assets and liabilities. Significant areas requiring the use of estimates are assessing the allowance of doubtful account and collectible of notes receivable. These estimates and assumptions are based on the Company’s historical results as well as management’s future expectations. The Company’s actual results may vary from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
106304 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
99456 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13565 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
90092 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86568 usd

Files In Submission

Name View Source Status
0001493152-23-027343-index-headers.html Edgar Link pending
0001493152-23-027343-index.html Edgar Link pending
0001493152-23-027343.txt Edgar Link pending
0001493152-23-027343-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lnby-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lnby-20230630_cal.xml Edgar Link unprocessable
lnby-20230630_def.xml Edgar Link unprocessable
lnby-20230630_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lnby-20230630_pre.xml Edgar Link unprocessable